Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design (Q41338220)
scientific article published on 28 May 2008
Language:
(P31) (Q13442814)
(P50) (Q42939171)
(Q56481169)
(Q4865631)
(Q78514357)
(Q109935303)
(Q114419529)
(Q114419533)
(Q73297881)
(Q125314797)
(P304) 7700-7710
(P407) (Q1860)
(P433) 15
(P478) 82
(P577) Wednesday, May 28, 2008
(P921) (Q49029021)
(Q14861085)
(P1433) (Q1251128)
(P1476) "Induction of plasma (TRAIL), TNFR-2, Fas ligand, and plasma microparticles after human immunodeficiency virus type 1 (HIV-1) transmission: implications for HIV-1 vaccine design" (language: en)
(P2093) Deanna M Crossman
John F Whitesides
Nadia Mensali
Sara E Miller
Charles F Reich
Li Qin
Stephen G Self
Laura E Jones
David S Pisetsky
(P2860) (Q36471285)
(Q36540014)
(Q24321270)
(Q34629012)
(Q36750429)
(Q36687910)
(Q21245029)
(Q33373336)
(Q36656715)
(Q36585103)
(Q27486378)
(Q35842625)
(Q40316213)
(Q34486229)
(Q36274922)
(Q33984320)
(Q35847699)
(Q33884028)
(Q29619124)
(Q40460735)
(Q34554352)
(Q35970213)
(Q36180409)
(Q22242965)
(Q22242981)
(Q36541079)
(Q34228730)
(Q35020357)
(Q39412581)
(Q28344659)
(Q40764496)
(Q33849293)
(Q34332663)
(Q34069516)
(Q39200565)
(Q36375339)
(Q36225040)
(Q29619099)
(Q27480421)
(Q36380292)
(Q37365561)
(Q40444875)
(Q33447605)
(Q45783344)
(Q45786097)
(Q45830789)
(Q44009472)
(Q45854355)
(Q45856562)
(Q45420228)
(Q51993308)
(Q47756393)
(Q43925949)
(Q42825776)
(Q42944373)
(Q45752978)
(Q54146049)
(Q58621898)
(Q60193080)
(Q71182378)
(Q62977671)
(Q81595423)
(Q61312703)
(Q71542182)
other details
description scientific article published on 28 May 2008

External Links